Aznar et al., 1974 - Google Patents
Fibrinogen Valencia A New Case of Congenital DysfibrinogenemiaAznar et al., 1974
- Document ID
- 9357043151756995390
- Author
- Aznar J
- Fernandez-Pavón A
- Regañóon E
- Vila V
- Orellana F
- Publication year
- Publication venue
- Thrombosis and Haemostasis
External Links
Snippet
A new case of dysfibrinogenemia is described, the proband had low fibrinogen level and a moderate hyperfibrinolysis. Attention is drawn to the florid hemorrhagic picture and its early presentation. The family history showed a moderate hyperfibrinolysis. It appeared that the …
- 108010049003 Fibrinogen 0 title abstract description 75
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sas et al. | Abnormal antithrombin III (antithrombin III ‘Budapest’) as a cause of a familial thrombophilia | |
Gralnick et al. | Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release | |
Griffin et al. | Deficiency of protein C in congenital thrombotic disease. | |
Al-Mondhiry et al. | Fibrinogen"" New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation | |
AU596951B2 (en) | Blood coagulation inhibiting proteins, processes for preparing them and their uses | |
AU610823B2 (en) | A process for the preparation of a factor V concentrate | |
Hallén et al. | Coagulation studies in liver disease | |
Mammen | Fibrinogen abnormalities | |
Biggs et al. | Tissue extract and the contact reaction in blood coagulation | |
CH635747A5 (en) | METHOD FOR PRODUCING A BLOOD-CLOTHING PRAEPARATION FROM HUMAN BLOOD PLASMA. | |
Soff et al. | Familial multiple coagulation factor deficiencies | |
Tavori et al. | The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis | |
Johnson et al. | Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X | |
Rosenberg et al. | A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia | |
Barrow et al. | Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease. | |
Lewis et al. | Effects of intravenous tissue thromboplastin in dogs: development of an anticoagulant | |
Briët et al. | Molecular variant of factor VII | |
Bithell | Hereditary dysfibrinogenemia. | |
Aznar et al. | Fibrinogen Valencia A New Case of Congenital Dysfibrinogenemia | |
Ouyang et al. | Properties of fibrinogen degradation products produced by α-and β-fibrinogenases of Trimeresurus mucrosquamatus snake venom | |
Kahn et al. | Prothrombin Brussels, a new congenital defective protein | |
O'kane et al. | Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin. | |
Denninger et al. | Congenital dysfibrinogenemia: fibrinogen Lille | |
Egberg | Coagulation studies in patients treated with Defibrase | |
Harder et al. | In vitro and in vivo induction of cryofibrinogen and “paracoagulation” by reptilase |